D1-like receptors distinguishing thieno-azecine regioisomers
- 5 August 2015
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 6 (9) , 1679-1686
Abstract
Designing ligands with D1/D5 subtype selectivity is a challenge because of the high identity within the receptor helices. Based on the lead compounds 1–3, the thieno-benzazecine regioisomers 4 and 5 were synthesized and biologically evaluated for their affinity towards the five dopamine receptor subtypes utilizing a radioligand binding affinity technique. Within the D1-like family, compound 4 showed 20 fold selectivity for the D5 subtype over D1 subtype (Ki = 3 nM, D1: 60 nM), while its regioisomer, compound 5 with a reversed thiophene position, prefers the D1 subtype over the D5 subtype (Ki = 4 nM, D5: 15 nM). The benzothieno-benzazecine analog 6 was shown to be one of the few azecine derivatives with high affinity for both the D1- and the D2-like family members in the same order of magnitude (Ki = 1.5 nM for D2 and 1.9 nM for D5). Thorough analysis of the amino acid residues constituting the binding pockets of the target dopamine receptor subtypes revealed that at the D5 receptor, either serine S 6.62 and threonine T 7.33 residues or a water network, stabilized by anionic amino acids could contribute to the selectivity pattern of the synthesized compounds.Keywords
This publication has 30 references indexed in Scilit:
- Update 1 of: Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric DisordersChemical Reviews, 2013
- Roles for nigrostriatal—not just mesocorticolimbic—dopamine in reward and addictionTrends in Neurosciences, 2009
- Dopamine D1receptor ligands: Where are we now and where are we goingMedicinal Research Reviews, 2008
- Schizophrenia: Multi-Attribute Utility Theory Approach to Selection of Atypical AntipsychoticsAnnals of Pharmacotherapy, 2007
- Dopamine Receptor SignalingJournal of Receptors and Signal Transduction, 2004
- A Positron Emission Tomography Study of Quetiapine in Schizophrenia: A Preliminary Finding of an Antipsychotic Effect With Only Transiently High Dopamine D2 Receptor OccupancyArchives of General Psychiatry, 2000
- Pharmacological Manipulation of D1-Dopamine Receptor Function in SchizophreniaNeuropsychopharmacology, 1999
- Dopamine Receptors: From Structure to FunctionPhysiological Reviews, 1998
- Lack of apparent antipsychotic effect of the D1-dopamine recepotr antagonist SCH39166 in acutely ill schizophrenic patientsPsychopharmacology, 1995
- Dopamine receptor pharmacologyTrends in Pharmacological Sciences, 1994